SCHEMBL7987443

SCHEMBL7987443

CCc1nc(O)c2c(ncn2Cc2cc(C)c(OCc3ccccc3)c(C)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HPGD P15428 3/20 0.36
HTT P42858 3/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
SCD O00767 1/20 0.33
DAPK1 P53355 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
LMNA P02545 3/20 0.33
MAPK14 Q16539 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992337 0.87 GAA (0.35) GAATSHRSMN1; SMN2HPGDHTT
SCHEMBL7975252 0.84 HPGD (0.45) GAATSHRSMN1; SMN2HPGDALDH1A1
SCHEMBL7987782 0.84 NPC1 (0.44) GAATSHRSMN1; SMN2HPGDHTT
SCHEMBL7987960 0.82 CYP11B1 (0.32) HPGDHTTTLR7CYP11B1CYP11B2
SCHEMBL7984378 0.80 CYP11B1 (0.42) GAASMN1; SMN2HPGDALDH1A1TLR7
SCHEMBL7974260 0.79 CYP11B1 (0.47) GAATSHRSMN1; SMN2HPGDHTT
SCHEMBL7973934 0.78 CYP11B1 (0.45) GAASMN1; SMN2HPGDALDH1A1KMT2A
SCHEMBL7987442 0.78 HPGD (0.46) GAASMN1; SMN2HPGDHTTALDH1A1
SCHEMBL7988129 0.78 MET (0.44) GAATSHRSMN1; SMN2HPGDALDH1A1
SCHEMBL7985651 0.77 CYP1A2 (0.41) GAASMN1; SMN2HPGDALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed